Literature DB >> 12426044

Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation.

R Lalonde1, M Dumont, M Staufenbiel, C Sturchler-Pierrat, C Strazielle.   

Abstract

Transgenic mice overexpressing the betaAPP gene with the Swedish mutation under the control of the murine thy-1 promoter show Alzheimer-like characteristics including the accumulation of Abeta protein in the cerebral cortex. Female 16-month-old APP23 transgenic mice were compared to age-matched non-transgenic mice in behavioral tests measuring spatial learning, exploration of environmental stimuli, anxiety, and motor coordination. APP23 transgenic mice had fewer fast ambulatory movements, either fast or slow stereotypy movements, and slow rears in a photocell activity chamber. The acquisition of spatial learning in the Morris water maze was impaired in APP23 transgenic mice, but not during the probe test or while swimming towards a visible platform. Neither were there intergroup differences in tests of anxiety or motor coordination. These results indicate that a learning deficit and hypoactivity, concordant with the early stages of Alzheimer's disease, characterize this mouse model with Abeta accumulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426044     DOI: 10.1016/s0006-8993(02)03476-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

Review 1.  Mouse models of Alzheimer's disease.

Authors:  Alicia M Hall; Erik D Roberson
Journal:  Brain Res Bull       Date:  2011-11-28       Impact factor: 4.077

Review 2.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

3.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

4.  Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.

Authors:  Rainer Hellweg; Peter Lohmann; Roman Huber; Alexander Kühl; Matthias W Riepe
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

5.  Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

Authors:  Debby Van Dam; Dorothee Abramowski; Matthias Staufenbiel; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2005-01-15       Impact factor: 4.530

6.  SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice.

Authors:  Supak Jenkitkasemwong; Adenike Akinyode; Elizabeth Paulus; Ralf Weiskirchen; Shintaro Hojyo; Toshiyuki Fukada; Genesys Giraldo; Jessica Schrier; Armin Garcia; Christopher Janus; Benoit Giasson; Mitchell D Knutson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-07       Impact factor: 11.205

7.  Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats.

Authors:  Nelson Ruiz-Opazo; Kenneth S Kosik; Lyle V Lopez; Pia Bagamasbad; Lorenz Rb Ponce; Victoria Lm Herrera
Journal:  Mol Med       Date:  2004 Jan-Jun       Impact factor: 6.354

8.  Regulatory roles of the NMDA receptor GluN3A subunit in locomotion, pain perception and cognitive functions in adult mice.

Authors:  Osama Mohamad; Mingke Song; Ling Wei; Shan Ping Yu
Journal:  J Physiol       Date:  2012-09-24       Impact factor: 5.182

9.  Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.

Authors:  Tetsuya Kimura; Shunji Yamashita; Tetsuya Fukuda; Jun-Mi Park; Miyuki Murayama; Tatsuya Mizoroki; Yuji Yoshiike; Naruhiko Sahara; Akihiko Takashima
Journal:  EMBO J       Date:  2007-11-15       Impact factor: 11.598

10.  Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer's disease.

Authors:  Debby Van Dam; Katrien Coen; Peter Paul De Deyn
Journal:  Psychopharmacology (Berl)       Date:  2007-11-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.